List of insiders holdings for ENANTA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Luly Jay R. President and CEO | 2025-02-14 17:05:29 | 1,703,616 0 | 1,703,616 | Form 13D |
| 2 | SAINTS CAPITAL GRANITE L.P. Saints Capital Granite LLC mRNA - Holdings LLC OBP (Adjunct) III - Holdings LLC OBP (Bermuda) III - Holdings LLC OBP III - Holdings LLC 10% Owner | 2014-02-13 15:24:51 | 1,656,575 0 | 1,656,575 | Form 13G |
| 3 | Goldberg Marc E. Director | 2013-12-06 18:20:57 | 0 547,606 | 547,606 | Form 4 |
| 4 | Or Yat Sun Chief Scientific Officer | 2025-02-14 16:40:00 | 374,535 0 | 374,535 | Form 4 |
| 5 | Gardiner Nathaniel S. Chief Legal Officer | 2024-02-27 18:31:52 | 153,501 35,926 | 189,427 | Form 4 |
| 6 | MELLETT PAUL J Chief Fin. & Admin Officer | 2025-02-14 16:37:57 | 95,884 0 | 95,884 | Form 4 |
| 7 | Adda Nathalie Sr. VP & Chief Medical Officer | 2022-04-05 19:54:18 | 75,567 0 | 75,567 | Form 4 |
| 8 | Kowalsky Matthew Paul Chief Legal Officer | 2024-11-27 17:10:18 | 75,000 0 | 75,000 | Form 4 |
| 9 | Luu Brendan Chief Business Officer | 2025-02-14 16:46:35 | 40,221 0 | 40,221 | Form 4 |
| 10 | Kieffer Tara Lynn Chief Product Strategy Officer | 2025-02-14 16:44:16 | 33,479 0 | 33,479 | Form 4 |
| 11 | Rottinghaus Scott T. Chief Medical Officer | 2025-02-14 16:42:37 | 24,807 0 | 24,807 | Form 4 |
| 12 | Ocain Tim Senior Vice President | 2019-02-13 21:40:08 | 17,547 0 | 17,547 | Form 4 |
| 13 | CARTER BRUCE L A Director | 2025-03-14 17:33:12 | 15,700 0 | 15,700 | Form 4 |
| 14 | FOLETTA MARK G Director | 2025-03-14 17:34:30 | 15,700 0 | 15,700 | Form 4 |
| 15 | Hata Yujiro S Director | 2025-03-14 17:35:47 | 15,700 0 | 15,700 | Form 4 |
| 16 | Peterson Kristine Director | 2025-03-14 17:43:00 | 15,700 0 | 15,700 | Form 4 |
| 17 | Russell Lesley Director | 2025-03-14 17:43:30 | 15,700 0 | 15,700 | Form 4 |
| 18 | Vance Terry Director | 2025-03-14 17:44:01 | 15,700 0 | 15,700 | Form 4 |
| 19 | Golumbeski George Director | 2020-02-28 17:08:24 | 10,000 0 | 10,000 | Form 4 |
| 20 | AFTING ERNST-GUENTER Director | 2016-02-12 16:07:50 | 6,000 0 | 6,000 | Form 4 |
| 21 | Poorvin David Director | 2013-03-22 16:14:10 | 5,800 0 | 5,800 | Form 4 |
| 22 | Buckley Stephen Jr. Director | 2019-03-01 20:03:06 | 5,000 0 | 5,000 | Form 4 |
| 23 | Verdine Gregory L. Director | 2013-03-28 16:24:41 | 3,324 0 | 3,324 | Form 4 |
| 24 | TVM V LIFE SCIENCE VENTURES GMBH & CO KG TVM V Life Science Ventures Management GmbH & Co. KG TVM IV GMBH & CO KG TVM IV Management GmbH & Co. KG TVM MEDICAL VENTURES GMBH & CO KG TVM Capital GmbH Birner Hubert Fischer Stefan Goll Alexandra SCHUHSLER HELMUT 10% Owner | 2016-02-19 16:46:58 | 0 0 | 0 | Form 13G |
| 25 | SHIONOGI & CO LTD 10% Owner | 2020-02-13 10:33:02 | 0 0 | 0 | Form 13G |